Terns Pharmaceuticals, Inc. TERN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

46/100

3/6 Pass

SharesGrow Intrinsic Value

Terns Pharmaceuticals, Inc. (TERN) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 Vivo Capital Surplus Fund VIII, L.P. 3,581,592 주 보유. 기타 주요 보유자에는 GORDON CARL L 및 ORBIMED ADVISORS LLC.

지난 12개월간 내부자는 29 건의 거래를 수행 TERN 주식 — 20 건 매수 (평가액 $1.75M) 및 8 건 매도 (평가액 $1.11M). 내부자 매수가 매도를 초과하여 회사 전망에 대한 자신감의 신호일 수 있습니다.

TERN 내부자 보유 현황

최대 보유자

Vivo Capital Surplus Fund VIII, L.P.

3,581,592 주

매수 (12개월)

$1.75M 평가액

매도 (12개월)

$1.11M 평가액

12개월 거래 활동

매수 69%

매도 28%

내부자 주요 보유자

#	이름	직책	보유 주식수	최종 신고일	상대적 규모
1	Vivo Capital Surplus Fund Viii, L.p.	Director	3,581,592	2022-09-08	100%
2	Gordon Carl L	10 Percent Owner	756,258	2024-07-17	21%
3	Orbimed Advisors Llc	10 Percent Owner	756,258	2024-07-17	21%
4	Aden Matthew J	SVP Worldwide Sales	500,000	2005-08-02	14%
5	Lav Biosciences Fund V, L.p.	Director	405,583	2022-11-28	11%
6	Burroughs Amy L.	Chief Executive Officer	288,976	2026-03-17	8%
7	Vivo Opportunity, Llc	10 Percent Owner	275,772	2024-04-03	8%
8	Russell Kerry Strong	Chief Medical Officer	240,000	2022-07-06	7%
9	Chase Jerry D	Chief Executive Officer	239,520	2004-09-10	7%
10	Taylor Arthur T	SVP, CFO	125,000	2003-05-30	3%
11	Kuriakose Emil	Chief Medical Officer	105,673	2026-04-02	3%
12	Gengos Andrew	Chief Financial Officer	101,788	2026-01-16	3%
13	Yoon Seokho Bryan	COO and General Counsel	91,940	2024-06-04	3%
14	Vignola Mark J.	Chief Financial Officer	83,811	2025-01-06	2%
15	Quirk Erin	President, Head of R&d	75,000	2024-01-25	2%
16	Lu Hongbo	Director	45,000	2025-06-12	1%
17	Orbimed Genesis Gp Llc	Director	38,450	2022-08-18	1%
18	Sundaram Senthil Vel	Chief Executive Officer	9,770	2023-06-02	0%
19	Taylor Ann Elizabeth	Director	4,676	2024-07-02	0%
20	Solomon Lewis	Director	3,000	2005-02-18	0%

최근 거래 (최근 12개월)

날짜	이름	직책	유형	주식수	주가	금액
2026-04-01	Kuriakose Emil	Chief Medical Officer	정보 매도	942	$52.75	$49.69K
2026-03-16	Burroughs Amy L.	Chief Executive Officer	정보 매도	2,770	$47.30	$131.03K
2026-02-17	Burroughs Amy L.	Chief Executive Officer	정보 매도	4,083	$39.80	$162.5K
2026-02-01	Quigley Jill M.	Director	RSU 부여	1,697	$34.60	$58.72K
2026-02-01	Tripuraneni Radhika	Director	RSU 부여	1,697	$34.60	$58.72K
2026-02-01	Azelby Robert	Director	RSU 부여	1,697	$34.60	$58.72K
2026-02-01	Turner Heather D	Director	RSU 부여	1,697	$34.60	$58.72K
2026-02-01	Kindler Jeffrey B	Director	RSU 부여	1,697	$34.60	$58.72K
2026-02-01	Fellows David A	Director	RSU 부여	2,828	$34.60	$97.85K
2026-01-14	Kuriakose Emil	Chief Medical Officer	RSU 부여	56,250	-	-
2026-01-15	Burroughs Amy L.	Chief Executive Officer	정보 매도	7,521	$37.53	$282.23K
2026-01-14	Burroughs Amy L.	Chief Executive Officer	RSU 부여	150,000	-	-
2026-01-14	Gengos Andrew	Chief Financial Officer	RSU 부여	68,750	-	-
2026-01-02	Kuriakose Emil	Chief Medical Officer	정보 매도	955	$38.36	$36.63K
2026-01-05	Burroughs Amy L.	Chief Executive Officer	옵션 행사 (매도)	150,000	-	-
2026-01-02	Burroughs Amy L.	Chief Executive Officer	옵션 행사	21,551	$4.64	$100K
2025-11-04	Quigley Jill M.	Director	정보 매도	24,520	$18.00	$441.36K
2025-10-01	Kuriakose Emil	Chief Medical Officer	정보 매도	944	$7.85	$7.41K
2025-07-01	Kuriakose Emil	Chief Medical Officer	정보 매도	853	$4.27	$3.64K
2025-06-27	Gengos Andrew	Chief Financial Officer	정보 매수	5,000	$3.93	$19.63K
2025-06-25	Burroughs Amy L.	Chief Executive Officer	정보 매수	23,314	$3.87	$90.23K
2025-06-16	Gengos Andrew	Chief Financial Officer	정보 매수	5,000	$3.95	$19.73K
2025-06-13	Gengos Andrew	Chief Financial Officer	정보 매수	5,000	$3.75	$18.75K
2025-06-11	Quigley Jill M.	Director	RSU 부여	45,000	$4.10	$184.5K
2025-06-11	Lu Hongbo	Director	RSU 부여	45,000	$4.10	$184.5K